Sort
172,184 grants matching “inflammation”
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
$2,294,476Andreas Stahl · University Of California Berkeley · UH3 · FY2021 · DK
Origins of Cystic Fibrosis Airway Disease
$2,294,370David A Stoltz · University Of Iowa · P01 · FY2020 · HL
Signal Transduction in Atherosclerosis
$2,294,361Garret A Fitzgerald · University Of Pennsylvania · P01 · FY2007 · HL
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)
$2,294,356Elaine Janine Abrams · Columbia University Health Sciences · R01 · FY2021 · HD
Origins of Cystic Fibrosis Airway Disease
$2,293,803David A Stoltz · University Of Iowa · P01 · FY2021 · HL
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,293,769Dartmouth College · P20 · FY2001 · RR
Stalled capillary flow: a novel mechanism for hypoperfusion in Alzheimer disease
$2,293,767Chris B Schaffer · Cornell University · RF1 · FY2021 · AG
Improving Cardiac Function After Myocardial Infarction
$2,293,603Steven R Houser · Temple Univ Of The Commonwealth · P01 · FY2016 · HL
Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
$2,293,425Pamela J Lein · University Of California At Davis · RF1 · FY2021 · AG
Origins of Cystic Fibrosis Airway Disease
$2,293,311David A Stoltz · University Of Iowa · P01 · FY2022 · HL
Cell Signaling of Host Defense
$2,293,033Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
DISCOVER Center: Cardiovascular Disease and Traffic-Related Air Pollution
$2,292,885Joel Daniel Kaufman · University Of Washington · P50 · FY2008 · ES
Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects
$2,292,799John Didsbury · T3d Therapeutics, Inc. · R01 · FY2019 · AG
Cognitive and immune impairments in sepsis survivors
$2,292,587Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2018 · AI
Cognitive and immune impairments in sepsis survivors
$2,292,587Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2017 · AI
Cognitive and immune impairments in sepsis survivors
$2,292,587Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2015 · AI
Cognitive and immune impairments in sepsis survivors
$2,292,587Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2014 · AI
Cognitive and immune impairments in sepsis survivors
$2,292,587Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2016 · AI
The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury
$2,292,551Dolly Mehta · University Of Illinois At Chicago · P01 · FY2024 · HL
Glycobiology of Inflammatory Lung Diseases
$2,291,264Ronald L Schnaar · Johns Hopkins University · P01 · FY2016 · HL
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma
$2,290,948Reynold Alexander Panettieri · Rutgers Biomedical/Health Sciences-Rbhs · P01 · FY2020 · HL
Hyaluronan Matrices in Vascular Pathologies
$2,289,976Vincent C. Hascall · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · HL
Metabolic pathways linked to immunity
$2,289,924Michael Sack · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance
$2,289,777Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)
$2,289,655Kabayam M Venkat Narayan · Emory University · P01 · FY2023 · HL